SPARC.

Takayuki Niitsu1,2, Toshiaki Kataoka3, Kiyoharu Fukushima1,2

  • 1Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.

PubMed
概括

空间转录学确定SPARC是跨间歇性肺部疾病 (ILDs) 的渐进性肺纤维化中的关键分子. 较高的SPARC水平表明无法分类的ILDs (uILDs) 的预后不佳,表明其作为预后标记物的潜力.